Diagnosis of c4d+ renal allograft acute humoral rejection by urine protein fingerprint analysis.
This study aimed to develop urine protein fingerprint models for the diagnosis of acute rejection (AR) and complement split product positive (C4d+) acute humoral rejection (AHR) following renal allograft transplantation. Urine samples from 101 renal transplant recipients were analysed by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry combined with bioinformatics. The patients comprised 36 with stable allograft function (stable group), 10 with acute tubular necrosis (ATN) and 55 with AR (20 with C4d- acute cellular rejection [ACR] and 15 with C4d+ AHR). The ATN group was differentiated from the stable group with a sensitivity and specificity of 100% (pattern 1). The stable group was differentiated from the AR group with a specificity of 86.4% and a sensitivity of 85.4% (pattern 2). The C4d- ACR subgroup was differentiated from the C4d+ AHR subgroup with a specificity and sensitivity of 95% and 80%, respectively (pattern 3). It is concluded that urine protein fingerprint analysis can provide a non-invasive tool to diagnose AR and C4d+ AHR.
The Kidney Disease Centre, Zhejiang University, Hangzhou, China.
H
H
Yang
Y
Y
Mao
J
J
Yu
J
J
Chen
Q
Q
He
Z
Z
Shou
J
J
Wu
Y
Y
Chen
S
S
Zheng
D000328:Adult; D015415:Biomarkers / Q000652:urine*; D015935:Complement C4b / Q000652:urine*; D019295:Computational Biology; D005260:Female; D006084:Graft Rejection / Q000652:urine*; D006801:Humans; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000652:urine*; D010449:Peptide Mapping; D011379:Prognosis; D012680:Sensitivity and Specificity; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D015415:Biomarkers; D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d